Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2719 results

Sort By:

Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

Study ID: NCT06770023
Start Date: 2025-12-11
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

4

Intervention / Treatment

Protek Solo Transseptal Cannula

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

Study ID: NCT07222579
Start Date: 2026-02
End Date: 2031-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

78

Intervention / Treatment

Subcutaneous Blinatumomab

Sponsor

West Virginia University

Source: clinicaltrials.gov

Share:
Add to list

TDAP in Burn Patients (Group 2)

Study ID: NCT07223684
Start Date: 2026-02-15
End Date: 2027-12-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Observational Cohort (No Intervention)

Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Source: clinicaltrials.gov

Share:
Add to list

Imaging Depression in Parkinson's Disease

Study ID: NCT06402955
Start Date: 2025-12-01
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

11C-UCB-J

ketamine hydrochloride

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Study ID: NCT06243731
Start Date: 2025-11-30
End Date: 2027-01-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

No Intervention

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Using TMS to Understand Neural Processes of Social Motivation

Study ID: NCT06274112
Start Date: 2025-12-01
End Date: 2029-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

TMS

Sponsor

Auburn University

Source: clinicaltrials.gov

Share:
Add to list

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

Study ID: NCT07223463
Start Date: 2026-03
End Date: 2030-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Tailored Program

Feedback Program (Uniform Standard of Care)

Sponsor

Children's Hospital Medical Center, Cincinnati

Source: clinicaltrials.gov

Share:
Add to list

THC + CBD and Memory Study

Study ID: NCT04855526
Start Date: 2025-12-01
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

9

Intervention / Treatment

High THC/No CBD Marihuana

High THC/High CBD Marihuana

No THC/No CBD Marihuana

Sponsor

Hartford Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Phase 3, Double-blind/double-dummy, Safety/efficacy/superiority of Sibutramine/topiramate XR in Adults with Overweight

Study ID: NCT05209984
Start Date: 2026-04
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1855

Intervention / Treatment

ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg

ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg

SIB Group Sibus (Sibutramine) 15mg

Placebo Group

Sponsor

Eurofarma Laboratorios S.A.

Source: clinicaltrials.gov

Share:
Add to list

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study ID: NCT06842498
Start Date: 2025-11-30
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

75

Intervention / Treatment

FG-3246

Sponsor

FibroGen

Source: clinicaltrials.gov

Share:
Add to list